Found 0 matching trials
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity PHASE2 This research study is studying the combination of anakinra and axicabtagen...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing N/A Exploring the precise medicine of patients with primary hepatobiliary cance...
Show More Location
Hepatic Surgery Center, Tongji Hospital, Huazhong University of Science and Technology
Learn More & Join Trial
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations PHASE1 This phase I trial studies the side effects and best dose of autologous CD8...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Transition to Home (TtH) After Preterm Birth NA Preterm birth is associated with significant and often life-long developmen...
Show More Location
Universitätsklinik für Kinderheilkunde Neonatologie Inselspital
Learn More & Join Trial
ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia PHASE1 This phase I/II trial studies the side effects and best dose of ABBV-383 an...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer Therapy PHASE2 To evaluate the efficacy and safety of Hetrombopag in secondary prevention ...
Show More Location
Jiangsu Cancer Hospital
Learn More & Join Trial
Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance PHASE2 This phase II trial studies how well the combination of ibrutinib and venet...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation PHASE1 This is a Phase 1/2, open-label, multicenter study designed to evaluate the...
Show More Location
Innovative Clinical Research Institute
Learn More & Join Trial
Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128) PHASE3 This study will examine the safety and efficacy of the addition of sitaglip...
Show More Location
Multiple Locations
Learn More & Join Trial
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study PHASE3 This phase III trial compares the effect of adding cabozantinib to avelumab...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Learn More & Join Trial